Clear Aligner Brands: How to Compare Aligner Systems When No Study Names a Winner

/ Why the brand is the smaller part of an aligner result

When deciding which aligner brand to choose, compare the clinical process before you compare the logo on the box. The brand matters because different companies may design different plans for the same mouth, but the name alone does not tell you whose teeth will track better. A lower-risk comparison asks who examines you, who approves the digital plan, what movements are being attempted, what happens if refinement is needed and whether retention is included. For a broader starting point, see our guide to clear aligner treatment.

A pilot study submitted the same initial records of 10 patients to Invisalign, ClearCorrect, 3M Clarity and Spark with standardised prescriptions; the four companies returned significantly different aligner counts, attachment counts and final canine relationships for the same patients (PubMed 41128735). That finding supports taking the proposed plan seriously, but it still does not name a winner. An overview of 18 systematic reviews concluded that clear aligner treatment is effective for mild to moderate malocclusions, has weaker outcomes in severe cases or for specific tooth movements and rests on a moderate level of evidence; this is class-level evidence about aligners in general, not one brand (PubMed 34993617).

Most class-level evidence was generated on Invisalign because a systematic review devoted to Invisalign found three randomised trials, 8 prospective studies and 11 retrospective studies, while a review of comparable size does not exist for another aligner brand (PubMed 30264270). In a clinical Invisalign study, the digital plan promised more than the teeth delivered, which is a warning about all aligner plans rather than a transferable score for other brands (PubMed 32620479). Orthodontic experts also reached consensus that aligners have biomechanical limits and did not agree on treatment duration (PubMed 40760282). No randomised clinical trial comparing treatment outcomes of one aligner brand against another was found in PubMed.

/ Eight aligner brands and the companies behind them

Clear aligner brands are easier to compare when the company behind each name is visible. The order below is neutral and does not rank treatment outcomes. Company size, case volume and manufacturing reach show who stands behind a product, but they do not prove that one patient will get a better result. Use this section as an orientation map, then read the one-to-one comparison for the brand you were quoted.

Align Technology describes Invisalign as a doctor-prescribed series of custom clear removable aligners based on a computer-simulated plan, and states that it received FDA 510(k) clearance for the system in 1998. Align Technology also stated in its second quarter 2026 release that doctors had treated approximately 23.5 million patients with Invisalign over the past 29 years. Mosdent provides Invisalign treatment, and its orthodontist Dr Ahmet Murat Artuç received an Align Technology award for documented Invisalign case volume among corporate customers during 2025; this measures documented case volume, not treatment outcomes, and Mosdent does not provide the other brands described here. Spark is listed by Envista Holdings within its Orthodontic Solutions business, aimed primarily at orthodontists, and Envista states that it shipped its one millionth Spark case in 2025; see Spark vs Invisalign. ClearCorrect is a Straumann Group brand, described by Straumann as using ClearQuartz material and a high flat trimline; Straumann announced in 2025 that ClearCorrect manufacturing for EMEA and APAC would transfer to Smartee, so brand ownership and regional manufacturing are not always the same; see ClearCorrect vs Invisalign.

Angelalign Technology, listed in Hong Kong under code 6699, reported 532,400 cases for fiscal year 2025 and says it serves more than 60 countries with design centres and manufacturing sites across several regions; see Angel Aligner vs Invisalign. Dentsply Sirona describes SureSmile as a digital treatment planning and appliance brand whose software can prescribe aligners, wires and indirect bonding trays; see SureSmile vs Invisalign. K Line Europe GmbH states that it manufactures Class IIa custom-made medical devices under EU rules, supplies dental professionals and business clients rather than patients, and also works as a private-label manufacturer; see K Line vs Invisalign. Nuvola says its aligners are designed and made in Italy from Evolution material; see Nuvola vs Invisalign. Orthero states that its headquarters are at ITU Ari Teknokent in Sariyer, Istanbul, with production facilities in Istanbul and Warsaw, and that Orthero aligners use 3 layer PET-G material made in Germany; see Invisalign, Orthero and ClearCorrect compared. Two Mosdent orthodontists hold Orthero Masters' Class training records, which is not the same as offering Orthero treatment.

/ Who plans the case and who supervises it

The aligner company to choose is the one attached to a treatment offer where planning responsibility and supervision are clearly stated. Ask who examines your teeth and gums before the scan, who approves or changes the digital setup and who checks during treatment that the teeth are following the aligners. A strong brand name cannot replace those answers. This is the practical separation between a labelled product and a clinically managed orthodontic treatment.

Align Technology describes Invisalign as doctor-prescribed and sold for use by orthodontists and general dental practitioners. Envista describes the customers of its Spark orthodontic business as primarily orthodontists. K Line states that it supplies dental professionals and business clients, not patients. Those company descriptions all point to a professional channel, but they still leave an important question for the clinic: does the treating clinician actively change the plan, or mainly accept what the manufacturer sends?

For some systems, the first digital setup is prepared or reviewed at the manufacturer level. Orthero says each case sent to its centre receives a 3D treatment plan prepared by its own orthodontic team, and K Line says its orthodontists review and clinically approve every digital setup before production. That can be useful, but it does not remove the treating clinician's responsibility to match the plan to the patient's mouth. In the United Kingdom, the General Dental Council states that decisions about suitability for orthodontic treatment must be based on a full assessment of oral health, that there is currently no effective substitute for a physical clinical examination as the basis of that assessment, and that direct-to-consumer aligner services fall within the legal definition of dentistry. In Mosdent's clinical judgement, the two questions that separate aligner offers most are who approves the plan and who sees the patient during treatment; this is clinical judgement, not a published finding.

/ Material, fit and attachments as they have been measured

Clear aligners are not all the same in material, fit or attachment design, but measured differences in plastic do not automatically translate into measured differences in final treatment outcome. Materials can differ in stiffness, hardness, thickness, force decay and tooth fit. Attachments can also change how a tooth responds to an aligner. The limit is that much of this evidence measures plastic behaviour or short clinical effects, not full brand-to-brand treatment results.

A systematic review of 24 articles found that clear aligner materials differ in hardness, stiffness, stress relaxation and creep, and that these properties deteriorate with thermoforming and intra-oral ageing; the review measured material behaviour, not treatment results (PubMed 38017152). An in-vitro micro-CT study fitted passive aligners from six systems to one resin cast and found statistically significant brand differences in aligner thickness and in the gap between aligner and tooth (PubMed 32390068). A systematic review of five clinical trials found that composite attachments mostly increased the effectiveness of clear aligner treatment, including anterior root torque, rotation, mesio-distal movement and posterior anchorage, although some trial findings were contradictory or non-significant (PubMed 35057250).

Manufacturer descriptions can help you understand what is being supplied. Align Technology states that SmartTrack material maintains more constant force over a longer period than conventional aligner materials; this is the manufacturer's statement, not an independent outcome comparison. Straumann says ClearCorrect uses ClearQuartz, a tri-layer material with an elastomeric layer and a high flat trimline. Orthero says its aligners are made from PET-G with 3 layer technology, that active aligners are 0.75 mm and Herotain retainers 1.0 mm thick, and that the material is made in Germany. Directly printed and in-house aligners are another category: laboratory reviews compare fabrication methods, and clinical studies of in-house aligners report outcomes for limited treatment, but no systematic review or clinical trial was found that directly compares clinic-made aligners with manufacturer-made aligners.

/ Movements aligners deliver and how often a refinement follows

Invisalign alternatives should be compared by the movements your case needs and by the refinement policy attached to the package. A brand quote that looks generous at the start may be less useful if the movement is hard to express or if extra aligners are limited. Rotation, intrusion, extrusion, vertical correction and expansion are recurring areas where aligners can need correction. Refinement should be treated as a normal treatment stage to ask about, not as proof that the first plan failed.

In a prospective clinical study of 38 Invisalign patients, the mean accuracy across all tooth movements was 50%, with buccal-lingual crown tip higher and rotation lower (PubMed 32620479). This is an Invisalign study, and it should not be copied across to Spark, ClearCorrect, Orthero or any other brand as if it were their score. It does show the central point of aligner treatment: the digital plan is a target, and teeth may need another aligner series to get closer to that target. A systematic review of eleven studies also reported that extrusion was the most difficult movement to control with clear aligners, followed by rotation, while upper molar distalisation was more predictable when a bodily movement of at least 1.5 mm was prescribed (PubMed 25412265).

A systematic review of twenty clinical studies linked the need for refinement after the first aligner series with malocclusion complexity, extraction treatment and severe spacing, and found reduced predictability for rotations, intrusion, vertical correction and transverse expansion (PubMed 42442043). In a questionnaire study, orthodontists commonly requested refinement, and more experienced specialists requested refinements more often (PubMed 40435056). A study of Invisalign patients found that treatment duration increased with refinements and that improvement did not continue after repeated refinements beyond a certain point (PubMed 35868952). Package rules also differ: Align Technology describes Invisalign Comprehensive as having a five-year treatment expiration with unlimited additional aligner sets before that date, Nuvola lists refinement phases by case level with expiry from one to three years, and Orthero publishes tiered packages where refinement numbers depend on the tier.

/ Wear time and retention, the two parts no brand can do for the patient

Aligner brands cannot wear the appliance or retain the result for the patient. If the aligners are out for too long, tooth movement can lag behind the plan no matter whose name is on the packet. After active treatment, retainers are a separate question in the quote. When comparing aligner brands, ask what daily wear is expected, how wear is monitored and exactly what retention product is included.

A systematic review of 24 studies on removable orthodontic appliances concluded that compliance is suboptimal and that patients routinely overestimate how long they wear the appliance; the studies covered removable appliances in general rather than aligners alone (PubMed 28651764). In a randomised clinical trial of 50 adults with mild crowding treated with Invisalign, both 22-hour and 12-hour daily wear protocols corrected front tooth irregularity, but correction of the lower front teeth was statistically greater in the 22-hour group (PubMed 41372110). This again is an Invisalign study, not a brand comparison, but it supports taking wear instructions seriously.

Digital reminders may help some patients, but the measurement has limits. In routinely collected app data from a German aligner company, self-reported poor compliance fell from 24.47% before electronic reminders to 9.32% afterwards; the study was written by company employees and measured self-reported wear, so it shows reminder effect rather than true wear time (PubMed 36198717). Retention has its own evidence boundary. A Cochrane review of retention found that without retention teeth tend to return towards their initial position, but it excluded aligner studies, so the need for retainers after aligners is inferred from patients treated with braces (PubMed 37219527). Retainers are also sold as product lines: Align Technology offers up to four sets of Vivera retainers, and Orthero lists one set of Herotain retainers in its packages. Inclusion in your quote should be checked explicitly.

/ Regulatory clearance and the published evidence behind each name

An ortho clear aligners brand name can have regulatory clearance without having trial evidence that it outperforms another brand. FDA 510(k) clearance means a device was found substantially equivalent to a device already on the market; it is not a finding that one aligner works better than another. Regulatory status also depends on the country where treatment is delivered. Evidence and clearance answer different questions, so both should be checked separately.

The FDA 510(k) database lists Align Technology's first sequential aligner clearance, K981095 for the Align System, with a decision date of 8 September 1998, and further Align Technology clearances under product code NXC up to 23 October 2025. The same database lists the Ormco Spark Aligner System under K182826, decided on 11 October 2018, and ClearCorrect under K082556, decided on 6 February 2009. It also lists K Clear by Kline Europe GmbH under K220726, decided on 16 March 2022, Nuvola by Gruppo Europeo Ortodonzia Srl under K222418, decided on 7 October 2022, and SureSmile Aligner by Dentsply Sirona under K260722, decided on 15 April 2026. For Orthero and Angelalign, no record could be matched with certainty in the FDA 510(k) database under the company names searched; that does not prove absence of clearance in every market.

European status needs its own confirmation. K Line Europe GmbH states that it manufactures transparent dental aligners as Class IIa custom-made medical devices under Regulation (EU) 2017/745 and holds ISO 13485 certification. The European conformity documents of the eight brands discussed here were not opened for this article, so the treating clinic should confirm the applicable regulatory position for the country of treatment. On published outcome evidence, Invisalign has the larger named literature, including the systematic review described earlier (PubMed 30264270). No randomised clinical trial comparing treatment outcomes of one aligner brand against another was found in PubMed.

/ Direct-to-consumer aligners and what the record shows

At home aligners vs Invisalign is mainly a difference in examination, supervision and business continuity. The plastic may look similar to a clinic-based aligner, but the route into treatment and the route for solving problems can be very different. The record contains both satisfaction reports and harm reports, so it should be read without exaggeration in either direction. The key question is whether a physical clinical examination and follow-up are built into the treatment offer.

The General Dental Council in the United Kingdom states that orthodontic suitability should be based on a full oral health assessment and that there is currently no effective substitute for a physical clinical examination as the foundation of that assessment. The American Association of Orthodontists issued a consumer alert in 2019 stating that some direct-to-consumer orthodontic companies do not involve in-person evaluation or in-person supervision by an orthodontist, and warned that incorrectly managed tooth movement could cause potentially irreversible problems including tooth and gum loss and changed bites. The British Orthodontic Society welcomed the General Dental Council statement in 2021 and advised anyone seeking orthodontic treatment to speak to a dentist or orthodontist first. The European Federation of Orthodontic Specialists Associations lists a Joint Declaration on the Remote Treatment of Malocclusions, but the text of the declaration itself was not opened for this article, so its wording is not quoted.

Business continuity is part of the record. SmileDirectClub told the US Securities and Exchange Commission that it and certain subsidiaries filed voluntary Chapter 11 petitions on 29 September 2023. Its archived customer notice dated 14 December 2023 stated that global operations were winding down immediately, that aligner treatment and customer care support were no longer available, that the Lifetime Smile Guarantee no longer existed and that customers on a payment plan were expected to continue payments. Dentsply Sirona states that it voluntarily suspended sale and marketing of Byte direct-to-consumer aligners and impression kits on 24 October 2024 and announced in January 2025 that Byte would no longer be offered to new patients.

The clinical record is mixed. A study of the FDA adverse event database from 1 January 2010 to 31 December 2020 found 651 reports associated with sequential aligners, 104 of them related to direct-to-consumer aligners; among those direct-to-consumer reports, 41.3% involved bite problems, 29.8% orofacial pain and 26.6% periodontal sequelae (PubMed 37504239). An online survey of 470 at-home aligner users recruited through social media and forums found 87.5% satisfaction, while 6.6% visited a dentist because of adverse-effect severity; the sample was self-selected, so it describes respondents rather than all users (PubMed 32718492). A review of 21 direct-to-consumer aligner websites found limited mention of pre-treatment dental health and indefinite retention, rated most information as poor or very poor, and concluded that consent based only on such websites is likely to be invalid (PubMed 33237579).